Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana

J Infect Dis. 2015 Feb 1;211(3):347-51. doi: 10.1093/infdis/jiu421. Epub 2014 Jul 28.

Abstract

We examined factors associated with mixed-strain Mycobacterium tuberculosis infections among patients at high risk for drug-resistant tuberculosis in Botswana. Thirty-seven (10.0%) of 370 patients with tuberculosis had mixed M. tuberculosis infections, based on 24-locus mycobacterial interspersed repetitive unit-variable number of tandem repeats genotyping. In log-binomial regression analysis, age <37 years (adjusted prevalence ratio [PR], 1.92; 95% confidence interval [CI], 1.01-3.57) and prior tuberculosis treatment (adjusted PR, 2.31; 95% CI, 1.09-4.89) were associated with mixed M. tuberculosis infections. Among human immunodeficiency virus-infected patients, prior tuberculosis treatment (adjusted PR, 2.11; 95% CI, 1.04-4.31) and CD4(+) T-cell count of <100 cells/μl (adjusted PR, 10.18; 95% CI, 2.48-41.71) were associated with mixed M. tuberculosis infections. Clinical suspicion of mixed M. tuberculosis infections should be high for patients with advanced immunosuppression and a prior history of tuberculosis treatment.

Keywords: HIV/AIDS; immune suppression; mixed tuberculosis infection; reinfection; tuberculosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Botswana / epidemiology
  • CD4-Positive T-Lymphocytes / immunology
  • Coinfection / epidemiology*
  • Coinfection / immunology*
  • Female
  • Genotype
  • Humans
  • Immune Tolerance / immunology*
  • Male
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / immunology*
  • Prevalence
  • Retrospective Studies
  • Risk
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / immunology*